HIGHLIGHTS
- who: Yingkun Xu and collaborators from the Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China have published the research work: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan- Cancer, in the Journal: BioMed Research International of 30/08/2022
- what: The authors comprehensively investigated the role of CDCA3 in 33 human cancer types by utilizing multiple cancer-related databases and bioinformatics analysis tools including TCGA GTEx GEPIA TIMER STRING Metascape and Cytoscape. This study explored the top . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.